See more : Telo Genomics Corp. (TDSGF) Income Statement Analysis – Financial Results
Complete financial analysis of EuroEyes International Eye Clinic Limited (1846.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EuroEyes International Eye Clinic Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Home Bistro Inc. (HBISD) Income Statement Analysis – Financial Results
- Silver Valley Metals Corp. (SILV.V) Income Statement Analysis – Financial Results
- Graubündner Kantonalbank (GRKP.SW) Income Statement Analysis – Financial Results
- Sparta Capital Ltd. (SAY.V) Income Statement Analysis – Financial Results
- Ramsay Health Care Limited (RHC.AX) Income Statement Analysis – Financial Results
EuroEyes International Eye Clinic Limited (1846.HK)
About EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 714.29M | 610.29M | 632.93M | 473.82M | 427.20M | 384.92M | 346.60M | 247.96M |
| Cost of Revenue | 378.77M | 339.45M | 320.39M | 259.72M | 250.51M | 228.88M | 223.54M | 167.07M |
| Gross Profit | 335.52M | 270.84M | 312.55M | 214.10M | 176.69M | 156.04M | 123.06M | 80.88M |
| Gross Profit Ratio | 46.97% | 44.38% | 49.38% | 45.19% | 41.36% | 40.54% | 35.51% | 32.62% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 39.94M | 37.18M | 28.46M | 24.38M | 87.58M | 25.14M | 10.14M | 9.38M |
| Selling & Marketing | 56.05M | 40.71M | 53.77M | 46.04M | 59.86M | 49.54M | 53.20M | 37.25M |
| SG&A | 95.98M | 77.89M | 82.22M | 70.43M | 147.44M | 74.68M | 63.35M | 46.63M |
| Other Expenses | 46.02M | 56.23M | 39.08M | 32.92M | -1.54M | 7.52M | -78.72M | 2.34M |
| Operating Expenses | 142.01M | 134.12M | 121.30M | 103.34M | 145.89M | 82.20M | -15.37M | 48.97M |
| Cost & Expenses | 520.78M | 473.57M | 441.69M | 363.06M | 396.40M | 311.07M | 208.16M | 216.04M |
| Interest Income | 19.33M | 1.14M | 138.00K | 2.52M | 2.45M | 197.11K | -309.32K | 138.65K |
| Interest Expense | 14.14M | 7.12M | 7.49M | 7.00M | 7.33M | 6.87M | 7.24M | 5.20M |
| Depreciation & Amortization | 87.35M | 80.72M | 74.66M | 67.33M | 66.59M | 55.87M | 49.77M | 42.26M |
| EBITDA | 292.10M | 220.44M | 278.80M | 173.62M | 95.33M | 131.28M | 179.62M | 71.26M |
| EBITDA Ratio | 40.89% | 36.27% | 43.88% | 36.48% | 22.31% | 33.11% | 53.91% | 28.57% |
| Operating Income | 193.51M | 132.81M | 191.26M | 111.06M | 30.25M | 73.08M | 131.19M | 32.34M |
| Operating Income Ratio | 27.09% | 21.76% | 30.22% | 23.44% | 7.08% | 18.98% | 37.85% | 13.04% |
| Total Other Income/Expenses | -2.90M | -3.83M | 4.41M | -12.41M | -9.10M | -7.40M | -11.88M | -6.42M |
| Income Before Tax | 190.61M | 128.98M | 195.67M | 98.65M | 21.20M | 65.68M | 119.31M | 25.92M |
| Income Before Tax Ratio | 26.69% | 21.13% | 30.92% | 20.82% | 4.96% | 17.06% | 34.42% | 10.45% |
| Income Tax Expense | 57.36M | 45.46M | 63.29M | 34.58M | 24.87M | 27.24M | 38.97M | 10.11M |
| Net Income | 131.24M | 89.47M | 133.56M | 65.58M | -3.66M | 38.45M | 80.34M | 15.81M |
| Net Income Ratio | 18.37% | 14.66% | 21.10% | 13.84% | -0.86% | 9.99% | 23.18% | 6.38% |
| EPS | 0.40 | 0.27 | 0.41 | 0.20 | -0.01 | 0.12 | 0.25 | 0.05 |
| EPS Diluted | 0.40 | 0.27 | 0.41 | 0.17 | -0.01 | 0.12 | 0.25 | 0.05 |
| Weighted Avg Shares Out | 332.25M | 331.90M | 328.38M | 375.64M | 256.52M | 317.33M | 317.33M | 317.33M |
| Weighted Avg Shares Out (Dil) | 332.25M | 332.28M | 329.16M | 375.64M | 256.52M | 317.33M | 317.33M | 317.33M |
Source: https://incomestatements.info
Category: Stock Reports